business

Acute Care Revenue Growth Helps Heron (HRTX) Reaffirm 2026 Guidance Despite Q1 Sales Decline

Yahoo Finance · May 11, 2026, 3:03 PM · Also reported by 4 other sources

Read full story on Yahoo Finance → More top stories

Also covered by

Bloomberg Tech Deutsche Telekom Nudges Up 2026 Guidance After T-Mobile Growth ARY News Greggs’ new menu helps bake in sales growth, shares rise Investing.com Veon lifts 2026 revenue outlook as Q1 sales jump 17% on digital surge Investing.com Earnings call transcript: Verrica Pharmaceuticals Q1 2026 shows revenue growth

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Acute Care Revenue Growth Helps Heron (HRTX) Reaffirm 2026 Guidance Despite Q1 Sales Decline

Also covered by

More in business